Sort
40,608 grants matching “prostate cancer”
Tak1, a novel prostate cancer tumor suppressor
$307,069Scott D Cramer · University Of Colorado Denver · R01 · FY2012 · CA
Mechanism and oncogenic role of lysine demethylase KDM5B in prostate cancer
$307,062Zhenbang Chen · Meharry Medical College · U54 · FY2017 · MD
Mechanisms of Transcriptional Control by p300
$307,053Kevin Gardner · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Roles of SRC-3 in Development and Disease
$307,041Jianming Xu · Baylor College Of Medicine · R01 · FY2012 · DK
MBD2 as a Target for Cancer Prevention and Treatment
$307,039William George Nelson · Johns Hopkins University · R01 · FY2007 · CA
Improved Cryosurgical Destruction of Prostate Cancer
$307,035John C Bischof · University Of Minnesota · R01 · FY2007 · CA
TARGETING PIM KINASE/LNCH19 AXIS IN ENZALUTAMIDE-RESISTANT PROSTATE CANCER
$307,000University Of Arizona · · FY2018 · Department of the Army
Mechanism of Gene Repression in the Kidney
$306,995Sanjeevkumar R Patel · University Of Michigan At Ann Arbor · R01 · FY2009 · DK
A dietary intervention clinical trial to reduce inflammation and improve outcomes in chronic pancreatitis
$306,994Thomas A Mace · Ohio State University · R01 · FY2025 · DK
INTRAOPERATIVE IMAGING OF CAVERNOUS NERVES IN RADICAL PROSTATECTOMY FOR PROSTATE CANCER...NEW GRANT, PRE-AWARD TRANSFER FROM STANFORD TO EMORY, SIGNED 8/29/2019, EFFECTIVE 9/15/2019, DISTRIBUTED 9/3/2019, FAADC ENTERED 9/3/2019 ENTRY ALLOWED ON 9/4/2019
$306,960Emory University · · FY2019 · Defense Health Agency
SOUTHWEST ONCOLOGY GROUP/UNIVERSITY OF CALIFORNIA, DAVIS
$306,945University Of California Davis · U10 · FY2000 · CA
Prostate cancer chemoprevention by penta-galloyl-glucose
$306,945Junxuan Lu · University Of Minnesota · R01 · FY2011 · CA
Biospecimen/Bioimaging Core
$306,933Robert B West · Stanford University · U54 · FY2025 · DK
Novel TYRO3 inhibitors for treatment of cancer
$306,926Xiaodong Wang · Univ Of North Carolina Chapel Hill · R01 · FY2024 · CA
Cellular Mechanisms Controlling Myc Protein Stability
$306,921Rosalie C Sears · Oregon Health & Science University · R01 · FY2007 · CA
Breast and Prostate Cancer Data Quality and Patterns of Care Study
$306,906Carin Irene Perkins · Minnesota State Dept Of Health · U01 · FY2006 · DP
Monitoring Recurrent Bladder Cancer with Electro-Phage Biosensors
$306,888Gregory A. Weiss · University Of California-Irvine · R33 · FY2017 · CA
NEUTRAL ENDOPEPTIDASE INACTIVATION IN ADVANCED PROSTATE
$306,837Weill Medical College Of Cornell Univ · R01 · FY2000 · CA
Quality of Life of Older Adult Long-Term Cancer Survivor
$306,828Gary T Deimling · Case Western Reserve University · R01 · FY2007 · CA
PTEN and Prostate Cancer Progression
$306,727Hong Wu · University Of California Los Angeles · R01 · FY2006 · CA
Antiapoptotic Role of NF-kB in Calcium Signaling
$306,706University Of Virginia Charlottesville · R01 · FY2003 · CA
Multimodality Molecular Nanoimaging of Cancer
$306,675Sanjiv S Gambhir · Stanford University · U54 · FY2015 · CA
A novel determinant of prostate cancer growth
$306,625Hannelore Heemers · Cleveland Clinic Lerner Com-Cwru · R01 · FY2024 · CA
Next generation bisphosphonates for chemo- and immuno-therapy
$306,616Eric Oldfield · University Of Illinois At Urbana-Champaign · R01 · FY2014 · CA
Ack1: Activation and Consequences in Prostate Cancer
$306,531Henry Shelton Earp · Univ Of North Carolina Chapel Hill · R01 · FY2009 · CA